Article Details

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics ... - KXAN

Retrieved on: 2024-03-31 23:36:01

Tags for this article:

Click the tags to see associated articles and topics

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics ... - KXAN. View article details on hiswai:

Excerpt

Public Relations Department. TEL: +81 (0)3-3817-5120. Eisai Inc. (U.S.) ... Biogen Inc. Jack Cox. + 1-781-464-3260. public.affairs@biogen.com. INVESTOR ...

Article found on: www.kxan.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo